Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Fellow, Clinical Oncology, Johns Hopkins University School of Medicine 2009 - 2012
  • Resident, Internal Medicine, University of North Carolina, Chapel Hill, School of Medicine 2005 - 2008
  • M.D., University of North Carolina - Chapel Hill 2004
• 

  Previous Appointments & Affiliations

  • Assistant Professor of Medicine, Medicine, Medical Oncology, Medicine 2015 - 2020
  • Medical Instructor in the Department of Medicine, Medicine, Medical Oncology, Medicine 2012 - 2014
• Recognition
• 

  In the News

  • NOV 9, 2018

    Duke Cancer Institute

    Cancer Straight Talk: Men Can Get Breast Cancer, Too
• Research
• 

  Selected Grants

  • Randomized, double-blind, phase 3 study of tucatinib or placebo in combination with ado-trastuzumab emtansine (T-DM1) for subjects with unresectable locally-advanced or metastatic HER2+ breast cancer awarded by Seattle Genetics, Inc 2019 - 2024
  • TBCRC45: AVIATOR: A Phase II Study Of Trastuzumab, Vinorelbine, and Avelumab ± PF-05082566 (4-1BB/CD137 Agonist) in HER2+ MBC awarded by Johns Hopkins University 2019 - 2023
  • Addressing Sexual Concerns in Breast Cancer Survivors: RCT of a Novel Couple-Based Intervention awarded by Fox Chase Cancer Center 2018 - 2023
  • A Randomized, Open Label, Phase III Trial to Evaluate the Efficacy and Safety of Palbociclib + Anti-HER2 Therapy + Endocrine Therapy vs. Anti-HER2 Therapy + Endocrine Therapy after Induction Treatment for Hormone Receptor Positive (HR+)/HER2-Positive awarded by Alliance Foundation Trials, LLC 2017 - 2023
  • AFT-05/PALLAS awarded by Alliance Foundation Trials, LLC 2016 - 2022
  • Couple Communication in Cancer: A Multi-method Examination awarded by Arizona State University 2016 - 2022
  • Optimizing Delivery of a Behavioral Cancer Pain Intervention Using a SMART awarded by National Institutes of Health 2016 - 2022
  • Oncothyreon ONT 380-206 awarded by Cascadian Therapeutics Inc. 2016 - 2021
  • A Phase III randomized, double-blind, placebo-controlled study of LEE011 or placebo in combination with tamoxifen and goserelin or a non-steroidal aromatase inhibitor (NSAI) and goserelin for the treatment of premenopausal women with hormone receptor awarded by Novartis Pharmaceuticals Corporation 2015 - 2021
  • Reimagine End of Life: An Online, Personalized Coping and Decision Aid for Metastatic Breast Cancer Patients and Providers awarded by Pfizer, Inc. 2016 - 2018
  • A randomized doubleblind, placebo controlled study of ribociclib in combination w/fulvestrant for the treatment of postmenopausal women w/hormone receptor positive, HER2-, advanced breast cancer who have received no or only 1line of prior endo treatm awarded by Novartis Pharmaceuticals Corporation 2015 - 2017
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Bennani-Baiti, Nabila, Hamed A. Daw, Claudiu Cotta, Peter Martin, Kelly W. Mitchell, Richard F. Ambinder, Roger Macklis, Raphael Pollock, and Timothy Spiro. “Low-grade follicular lymphoma of the small intestine: a challenge for management.” Semin Oncol 38, no. 6 (December 2011): 714–20. https://doi.org/10.1053/j.seminoncol.2011.08.002.
       Full Text  Link to Item
    • Mitchell, Kelly W., Lisa A. Carey, and Jeffrey Peppercorn. “Reporting of race and ethnicity in breast cancer research: room for improvement.” Breast Cancer Res Treat 118, no. 3 (December 2009): 511–17. https://doi.org/10.1007/s10549-009-0411-4.
       Full Text  Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.